Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 13.02.2025
Mynaric AG
Munich, February 13, 2025 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, announces that it received a delisting notification dated February 10, 2025 (the “Delisting Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”).
A [ … ]
Thu, 13.02.2025
NEAG Norddeutsche Energie AG
NEAG Norddeutsche Energie AG and Zencap Asset Management successfully concluded a Junior Debt Transaction
NEAG Norddeutsche Energie AG (“NEAG”) and Zencap Asset Management (“Zencap AM”) are delighted to announce that they have concluded a junior debt facility agreement for a German onshore wind portfolio with an aggregate capacity of 77,2 MW. Zenca [ … ]
Thu, 13.02.2025
Aricolin Investments S.A.
Bondholders of the corporate bond “Poco Bond” (ISIN: DE000A2R28T1) resolve to amend the terms and conditions of the bond
Madrid, February 13, 2025 - The bondholders of the corporate bond “Poco Bond” (ISIN: DE000A2R28T1) (“POCO Bond”) of Aricolin Investments S.A. have resolved in a vote without meeting according to still preliminary results with the [ … ]
Thu, 13.02.2025
Pentixapharm Holding AG
Berlin, Germany, February 13, 2025 – Data from the first-in-human radioligand-therapy for muscle invasive bladder cancer (MIBC) using Pentixapharm’s Lu177-PentixaTher compound will be shown at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO-GU 2025) in San Francisco, CA.
The presentation features a case study of a [ … ]
Thu, 13.02.2025
The NAGA Group AG
The NAGA Group: Research update from Warburg available – “BUY” recommendation confirmed and price target adjusted
Warburg
Recommendation
BUY
(BUY)
Price target (in EUR)
1.20
(1.30)
Upside potential (closing price EUR 0.63)
90%
Hamburg, 13 February 2025 – The price target of The NAGA Group AG (XETRA: N4G, ISIN: DE000 [ … ]
Thu, 13.02.2025
GBC AG
Dear Sir or Madam,
We are pleased to invite you to join us online for the 14th International Investment Forum (IIF) on February 25, 2025, starting at 9:55 AM (CET).
A Premier Platform for Insights & Investment Opportunities
As a live online event, the International Investment Forum (IIF) provides direct access to publicly listed companies fr [ … ]
Thu, 13.02.2025
Uniper SE
Uniper SE: Uniper successfully closes the 2024 financial year with an Adjusted EBITDA of over EUR 2.6 billion and provides an outlook for the fiscal year 2025
Based on preliminary figures, Uniper expects an Adjusted EBITDA of EUR 2.612 billion for the financial year 2024 which is within the outlook of EUR 2.5 to 2.8 billion. The Adjusted Net Income [ … ]
Thu, 13.02.2025
SHS Gesellschaft für Beteiligungsmanagement mbH
Tuebingen / 13.02.2025
Healthcare specialist SHS Capital has taken an important step in its long-term succession planning and is securing further growth.
Lukas Maucher, who joined SHS in 2022 from one of the Big Four auditing firms and has served as CFO since then, will take on the role of Managing Partner, overseeing finance and risk manageme [ … ]
Thu, 13.02.2025
Lindis Biotech GmbH
PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY
LINDIS BIOTECH AND PHARMANOVIA ANNOUNCE EUROPEAN MARKETING AUTHORISATION APPROVAL FOR CATUMAXOMAB, A FIRST-IN-CLASS TREATMENT FOR MALIGNANT ASCITES
CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER
UNDER A LICEN [ … ]
Thu, 13.02.2025
Eckert & Ziegler SE
Berlin, 13 February 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) has suffered a cyber attack on parts of its IT systems. The systems were temporarily shut down proactively and disconnected from the internet to minimise any potential impact. The IT systems and the effects of the attack are currently being examined. The utmost care is be [ … ]
